AstraZeneca PLC Receives Award for Pioneering Use of SAFE-BioPharma, LLC Digital Signatures to Sign Electronic Submissions to FDA

Published: Jun 03, 2008

FT. LEE, N.J.--(BUSINESS WIRE)--AstraZeneca Pharmaceuticals (AZ) has received Bio-IT World magazine’s 2008 Best Practices Grand Prize for its pioneering use of SAFE-BioPharma™ digital signatures to sign electronic submissions made through the FDA’s eSubmissions Gateway.

Back to news